Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2781.69% is 43% above its 5-year average of -4864.87%, near the high end of its 5-year range (-18479.69%–-53.77%).
71.78% above its 12-month average of -9856.80%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18479.69%.
OPERATING MARGIN
-2781.69%
OPERATING MARGIN AVG TTM
-9856.80%
OPERATING MARGIN AVG 3Y
-7563.20%
OPERATING MARGIN AVG 5Y
-4864.87%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+71.78%
CURRENT VS 3Y AVG
+63.22%
CURRENT VS 5Y AVG
+42.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Nexalin Technology, Inc.
Market Cap
$3.58M
Operating Margin
-2781.69%
TTM Avg
-9856.80%
3Y Avg
-7563.20%
5Y Avg
-4864.87%
Market Cap
$3.59M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$3.55M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.39M
Operating Margin
-3.14%
TTM Avg
-81.95%
3Y Avg
-224.77%
5Y Avg
-179.82%
Market Cap
$3.28M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
Market Cap
$3.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.26M
Operating Margin
-23.11%
TTM Avg
-1618.34%
3Y Avg
-814.04%
5Y Avg
-551.20%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.58M | -2781.69% | -9856.80% | -7563.20% | -4864.87% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.59M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| Evogene Ltd. (EVGN)vs › | $3.55M | -364.24% | -350.71% | -763.84% | -1461.60% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.39M | -3.14% | -81.95% | -224.77% | -179.82% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.28M | 0.00% | 0.00% | -518.01% | -1135.32% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.26M | -23.11% | -1618.34% | -814.04% | -551.20% |
| MBody AI Ltd. (MBAI)vs › | $3.16M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
79.7%
Operating Margin
-2781.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -18479.69% |
| 2026-03-31 | -14179.95% |
| 2025-12-31 | -1403.86% |
| 2025-09-30 | -12924.30% |
| 2025-06-30 | -2296.22% |
| 2025-03-31 | -4903.63% |
| 2024-12-31 | -10579.48% |
| 2024-09-30 | -6962.11% |
| 2024-06-30 | -4832.41% |
| 2024-03-31 | -1364.81% |
| 2023-12-31 | -7910.37% |
| 2023-09-30 | -10017.57% |
| 2023-06-30 | -2467.25% |
| 2023-03-31 | -2550.48% |
| 2022-12-31 | -1872.83% |
| 2022-09-30 | -53.77% |
| 2022-06-30 | -107.44% |
| 2022-03-31 | -116.02% |
| 2021-12-31 | -2406.30% |
| 2021-09-30 | -3207.88% |
| 2021-06-30 | -7140.79% |
| 2021-03-31 | -4475.60% |
| 2020-12-31 | -1261.18% |
| 2020-09-30 | -1995.37% |
| 2020-06-30 | -1238.67% |
| 2020-03-31 | -1238.66% |
